This year’s upcoming respiratory season presents new uncertainty and risk on the heels of the COVID-19 pandemic. AMI Expeditionary Healthcare is pleased to have partnered with a leader in rapid diagnostics to fight this battle, LifeSign Status™. “By offering the LifeSign Status™ COVID-19 Flu A&B rapid combo test to our testing centers, laboratories, hospitals, medical offices and clinics around the globe as respiratory season approaches and back-to-school efforts are underway, the partnership will support and expand our efforts by increasing the access to US-made rapid diagnostic screening solutions that are needed to properly address the ongoing Covid-19 Pandemic, Influenza A&B respiratory illnesses and more,” said Dr. Andrew Walker, AMI Founder and CEO.
Learn more about AMI’s services and or email sales@ami.health.
Follow us on Social Media